| 000 | 01306 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250515233932.0 | ||
| 264 | 0 | _c20100915 | |
| 008 | 201009s 0 0 eng d | ||
| 022 | _a1532-8708 | ||
| 024 | 7 |
_a10.1053/j.seminoncol.2010.06.001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSaad, Fred | |
| 245 | 0 | 0 |
_aZoledronic acid use in patients with bone metastases from renal cell carcinoma or bladder cancer. _h[electronic resource] |
| 260 |
_bSeminars in oncology _cJun 2010 |
||
| 300 |
_aS38-44 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBone Neoplasms _xprevention & control |
| 650 | 0 | 4 |
_aCarcinoma, Renal Cell _xdrug therapy |
| 650 | 0 | 4 |
_aDiphosphonates _xtherapeutic use |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazoles _xtherapeutic use |
| 650 | 0 | 4 |
_aKidney Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 |
_aUrinary Bladder Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aZoledronic Acid |
| 700 | 1 | _aEastham, James A | |
| 773 | 0 |
_tSeminars in oncology _gvol. 37 Suppl 1 _gp. S38-44 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1053/j.seminoncol.2010.06.001 _zAvailable from publisher's website |
| 999 |
_c20021300 _d20021300 |
||